QNCX — Quince Therapeutics, Inc.

QNCXQuince Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · quincetx.com

1.135USD-5.22%Mkt Cap: 21.91M USDP/E: —Last update: 2026-06-01

Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap21.91M USD

Enterprise Value875.85K USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-83.98M USD

Revenue/Share—

Last Price1.135 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees38

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.98

PEG—

EV/EBITDA-0.02

EV/Revenue—

P/S—

P/B1.01

EPS (TTM)-10.50

EPS (Forward)-1.17

52W Range

0.79001% of range45.50

52W High45.50 USD

52W Low0.7900 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE235.14%

ROA-89.80%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-41.42M USD

CapEx (TTM)352.00K USD

FCF Margin—

FCF Yield-139.58%

Net Debt-17.87M USD

Net Debt/EBITDA0.37

Balance Sheet

Debt/Equity-0.52

Current Ratio2.92

Quick Ratio2.07

Book Value/Sh1.136 USD

Cash/Share1.114 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateApr 13, 2026

Analyst Consensus

Rating—

Target (Mean)0.0000 USD

Target Range0.0000 USD – 0.0000 USD

# Analysts1

Ownership

Shares Out.19.56M

Float15.71M

Insiders3.19%

Institutions9.98%

Short Interest

Short Ratio1.4d

Short % Float10.82%

Short % Out.10.79%

Shares Short1.76M

Short (prev mo.)1.95M

Technical

SMA 501.185 (-4.2%)

SMA 20014.20 (-92.0%)

Beta—

S&P 52W Chg27.70%

Avg Vol (30d)1.81M

Avg Vol (10d)3.36M

Technical Indicators

RSI (14)46.7

MACD-0.0702

MACD Signal-0.0985

MACD Hist.+0.0283

BB Upper1.362 USD

BB Middle1.188 USD

BB Lower1.015 USD

BB Width29.25%

ATR (14)0.1575 USD

Vol Ratio (20d)0.27x